CTI BioPharma (CTIC) Announces Pricing of 50,000 Share Series N-1 Conv. Preferred Stock Offering
Tweet Send to a Friend
CTI BioPharma (NASDAQ: CTIC) announced the pricing of an underwritten public offering of 50,000 shares of its Series N-1 Preferred ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
